P Joling, L H Rademakers, M A Verdaasdonk, D Zimmermann, D C Spierings, N Werner, R A de Weger, J C van den Tweel
{"title":"Interaction of tumour cells with cultured stromal cells from human bone marrow.","authors":"P Joling, L H Rademakers, M A Verdaasdonk, D Zimmermann, D C Spierings, N Werner, R A de Weger, J C van den Tweel","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Adhesion of tumour cells to cultured bone marrow stromal cells has been studied in an in vitro model system. Stromal cells were isolated from bone marrow aspirates. Immunohistochemical and electron microscopical analysis revealed a uniform cell monolayer of myofibroblastic cells, expressing fibroblast antigens and smooth muscle actin. Cell interactions with tumour cells lines showed different patterns. The K562 cells bound in low numbers to stromal cells. HEL-DR- and HL60 cells adhered to stromal cells showing an enlarged cell contact area (spreading) attenuated by distinct contact sites and they invaded the monolayer. Adhesion molecules, important for cell contacts, were detected on tumor cells. Different VLA antigens were detected on tumour cells, but on stromal cells only VLA-5 and CD29 were found. In vitro inhibition studies with mAbs against adhesion molecules indicated two major pathways for binding of tumour cells to stromal cells: VCAM-1/VLA-4 and fibronectin/VLA-5. Variation in inhibition of mAbs to VLA-4 and VCAM-1 indicated the existence of critical epitopes in the adhesion of tumour cells.</p>","PeriodicalId":76738,"journal":{"name":"Thymus","volume":"23 2","pages":"115-26"},"PeriodicalIF":0.0000,"publicationDate":"1994-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Thymus","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Adhesion of tumour cells to cultured bone marrow stromal cells has been studied in an in vitro model system. Stromal cells were isolated from bone marrow aspirates. Immunohistochemical and electron microscopical analysis revealed a uniform cell monolayer of myofibroblastic cells, expressing fibroblast antigens and smooth muscle actin. Cell interactions with tumour cells lines showed different patterns. The K562 cells bound in low numbers to stromal cells. HEL-DR- and HL60 cells adhered to stromal cells showing an enlarged cell contact area (spreading) attenuated by distinct contact sites and they invaded the monolayer. Adhesion molecules, important for cell contacts, were detected on tumor cells. Different VLA antigens were detected on tumour cells, but on stromal cells only VLA-5 and CD29 were found. In vitro inhibition studies with mAbs against adhesion molecules indicated two major pathways for binding of tumour cells to stromal cells: VCAM-1/VLA-4 and fibronectin/VLA-5. Variation in inhibition of mAbs to VLA-4 and VCAM-1 indicated the existence of critical epitopes in the adhesion of tumour cells.
在体外模型系统中研究了肿瘤细胞与培养的骨髓基质细胞的粘附。从骨髓抽吸液中分离基质细胞。免疫组织化学和电镜分析显示,肌成纤维细胞呈均匀单层,表达成纤维细胞抗原和平滑肌肌动蛋白。细胞与肿瘤细胞系的相互作用表现出不同的模式。K562细胞少量与基质细胞结合。hell - dr -和HL60细胞粘附在基质细胞上,细胞接触面积增大(扩散),因不同的接触部位而减弱,并侵入单层。在肿瘤细胞上检测到对细胞接触很重要的粘附分子。在肿瘤细胞上检测到不同的VLA抗原,而在基质细胞上仅检测到VLA-5和CD29。单克隆抗体对黏附分子的体外抑制研究表明,肿瘤细胞与基质细胞的结合有两条主要途径:VCAM-1/VLA-4和纤连蛋白/VLA-5。单克隆抗体对vca -4和VCAM-1的抑制变化表明肿瘤细胞粘附中存在关键表位。